Bente P van den Boom

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Venous Thromboembolism

Ejection Fraction

Cardiovascular Events

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Journal of thrombosis and haemostasis : JTH

International journal of laboratory hematology

This page only lists publications with an associated author ORCID identifier.

Publications

J P Luyendyk, Bente P van den Boom, William Bernal, Vishal C Patel
Von Willebrand factor as a predictor of mortality in acute-on-chronic liver failure: Do not throw out the baby with the bathwater. Liver international : official journal of the International Association for the Study of the Liver 44 (2) (2023)
J P Luyendyk, Bente P van den Boom, William Bernal, Vishal C Patel
Von Willebrand factor as a predictor of mortality in acute-on-chronic liver failure: Do not throw out the baby with the bathwater. Liver international : official journal of the International Association for the Study of the Liver (2023)
J P Luyendyk, Bente P van den Boom, William Bernal, Vishal C Patel
Von Willebrand factor as a predictor of mortality in acute-on-chronic liver failure: Do not throw out the baby with the bathwater. Liver international : official journal of the International Association for the Study of the Liver 44 (2) (2023)
Bente P van den Boom, Marilena Stamouli, Jennifer Timon, William Bernal, Annabel Blasi, Jelle Adelmeijer, Javier Fernandez, J P Luyendyk, Vishal C Patel
Von Willebrand factor is an independent predictor of short-term mortality in acutely ill patients with cirrhosis. Liver international : official journal of the International Association for the Study of the Liver (2023)
Bente P van den Boom, J P Luyendyk
Pathophysiology and management of bleeding and thrombosis in patients with liver disease. International journal of laboratory hematology (2022)
Bente P van den Boom, Fien A von Meijenfeldt, Jelle Adelmeijer, Lara N Roberts, William Bernal, J P Luyendyk
Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis. Journal of thrombosis and haemostasis : JTH 19 (6) (2021)